Prognostic factors associated with locally advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by surgical resection
Metrics: PDF 885 views | HTML 1280 views | ?
Yongkun Sun1, Lin Yang1, Chengfeng Wang1, Dongbing Zhao1, Jianqiang Cai1, Wenbin Li1, Wen Zhang1, Jing Huang1 and Aiping Zhou1
1National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Lin Yang, email: firstname.lastname@example.org
Keywords: prognostic factors, locally advanced gastric cancer, neoadjuvant chemotherapy, gastrectomy
Received: February 07, 2017 Accepted: July 25, 2017 Published: September 06, 2017
In this retrospective study, we analyzed prognostic factors associated with survival outcomes in 73 locally advanced gastric cancer patients treated with neoadjuvant chemotherapy (NAC) followed by surgical resection. Median disease-free survival (DFS) for 64 patients that received R0 resection was 685 days, whereas median overall survival (OS) for 73 patients was 930 days. Multivariate analysis demonstrated that post-treatment nodal stages (P = 0.002), nervous invasion (P = 0.0492) and serum CA199 levels (P = 0.0398) were independent prognostic factors for DFS. Nodal stages (P = 0.0007), presence of nervous invasion (P = 0.0259) and non-radical resection (P = 0.0165) were independent prognostic factors for OS. These results indicate that post-treatment nodal stages, neural invasion and serum CA199 levels are all associated with poor DFS. Moreover, post-treatment nodal stage, resection type and neural invasion status are independent prognostic factors for OS.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.